Michele Milella Selected Research

Michele Milella Research Topics

Disease

91	Neoplasms (Cancer) 07/2022 - 06/2003
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 12/2005
30	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 07/2004
23	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 12/2010
23	Breast Neoplasms (Breast Cancer) 12/2021 - 11/2002
20	Adenocarcinoma 06/2022 - 07/2004
17	Lung Neoplasms (Lung Cancer) 06/2022 - 12/2005
11	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2015
10	Disease Progression 01/2021 - 07/2004
8	Melanoma (Melanoma, Malignant) 04/2022 - 08/2009
8	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 05/2010
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2007
5	Chronic Hepatitis C 05/2021 - 11/2006
5	Merkel Cell Carcinoma 01/2020 - 10/2016
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2012 - 05/2002
4	Adenocarcinoma of Lung 01/2022 - 10/2009
4	Infections 12/2020 - 10/2014
4	Fibrosis (Cirrhosis) 10/2019 - 09/2014
3	Carcinoma (Carcinomatosis) 01/2022 - 09/2005
3	Sarcoma (Soft Tissue Sarcoma) 10/2020 - 02/2018
3	Genomic Instability 10/2019 - 01/2015
3	Carcinogenesis 01/2018 - 08/2007
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2015 - 01/2009
3	Neutropenia 03/2012 - 09/2005
2	Microsatellite Instability 06/2022 - 01/2019
2	Inflammation (Inflammations) 11/2021 - 10/2020
2	Pain (Aches) 12/2020 - 12/2005
2	Chronic Renal Insufficiency 10/2019 - 10/2017

Drug/Important Bio-Agent (IBA)

20	Gemcitabine FDA Link 01/2021 - 09/2005
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 05/2002
13	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2003
12	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2003
9	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2017
9	Pharmaceutical PreparationsIBA 01/2019 - 01/2008
8	cabozantinibIBA 01/2022 - 01/2018
6	Biological ProductsIBA 01/2022 - 12/2008
6	InterferonsIBA 01/2020 - 11/2006
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2008
5	PlatinumIBA 01/2022 - 12/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 06/2006
5	Antiviral Agents (Antivirals)IBA 03/2020 - 01/2017
5	Everolimus FDA Link 01/2018 - 12/2010
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2013 - 08/2008
5	Aromatase InhibitorsIBA 08/2010 - 10/2005
4	NivolumabIBA 06/2022 - 01/2015
4	Fluorouracil (Carac)FDA LinkGeneric 02/2021 - 07/2004
4	130-nm albumin-bound paclitaxelIBA 01/2021 - 04/2015
4	Protein Isoforms (Isoforms)IBA 11/2020 - 08/2008
4	Phosphotransferases (Kinase)IBA 10/2020 - 06/2003
4	TensinsIBA 07/2020 - 03/2019
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2020 - 03/2019
4	avelumabIBA 01/2020 - 10/2016
4	AntigensIBA 01/2019 - 09/2006
4	AntibodiesIBA 10/2016 - 10/2007
4	Ribavirin (Virazole)FDA LinkGeneric 07/2016 - 01/2014
4	Sunitinib (Sutent)FDA Link 01/2015 - 12/2010
4	Capecitabine (Xeloda)FDA Link 11/2014 - 09/2008
4	Docetaxel (Taxotere)FDA Link 08/2013 - 01/2005
4	Imatinib Mesylate (Gleevec)FDA Link 02/2012 - 06/2003
4	Trastuzumab (Herceptin)FDA Link 12/2008 - 11/2004
3	Pemetrexed (MTA)FDA Link 01/2022 - 04/2006
3	pembrolizumabIBA 01/2022 - 01/2015
3	Hormones (Hormone)IBA 11/2021 - 08/2009
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2021 - 01/2020
3	folfirinoxIBA 02/2021 - 01/2011
3	Mitogen-Activated Protein KinasesIBA 10/2020 - 05/2002
3	Albumin-Bound Paclitaxel FDA Link 10/2020 - 04/2015
3	Sorafenib (BAY 43-9006)FDA Link 11/2019 - 12/2010
3	Monoclonal AntibodiesIBA 10/2016 - 12/2008
3	Gefitinib (Iressa)FDA Link 05/2015 - 12/2005
3	AutoantibodiesIBA 09/2013 - 10/2007
3	Cisplatin (Platino)FDA LinkGeneric 08/2013 - 02/2007
3	MTOR InhibitorsIBA 10/2012 - 12/2010
3	Celecoxib (Celebrex)FDA Link 01/2009 - 07/2004
3	AnthracyclinesIBA 12/2008 - 07/2008
3	Taxoids (Taxanes)IBA 09/2008 - 06/2006
3	Tamoxifen FDA LinkGeneric 01/2008 - 10/2005
2	glecaprevir and pibrentasvirIBA 05/2021 - 10/2019
2	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 06/2012
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 01/2019
2	AfatinibIBA 01/2020 - 11/2014
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 06/2015
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 08/2019 - 01/2015

Therapy/Procedure

68	Therapeutics 04/2022 - 02/2004
34	Drug Therapy (Chemotherapy) 01/2022 - 09/2004
20	Immunotherapy 06/2022 - 01/2015
10	Radiotherapy 06/2022 - 08/2009
7	Precision Medicine 01/2022 - 12/2017
5	Neoadjuvant Therapy 01/2022 - 07/2008
5	Adjuvant Chemotherapy 11/2018 - 06/2006
4	Combination Drug Therapy (Combination Chemotherapy) 05/2020 - 03/2011
3	Aftercare (After-Treatment) 01/2018 - 09/2017
2	Nutritional Support (Artificial Feeding) 01/2022 - 01/2020
2	Castration 01/2022 - 12/2020
2	Preoperative Exercise 09/2021 - 08/2021
2	Enzyme Replacement Therapy 01/2021 - 01/2020
2	Duration of Therapy 10/2019 - 12/2010